n,n-dimethylarginine has been researched along with Cardiomyopathies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderssohn, M; Böger, RH; Frey, N; Lüneburg, N; Lutz, M; Rosenberg, M; Schwedhelm, E; Zugck, C | 1 |
| Benedetto, FA; Cutrupi, S; Malatino, L; Mallamaci, F; Pizzini, P; Tripepi, G; Zoccali, C | 1 |
2 other study(ies) available for n,n-dimethylarginine and Cardiomyopathies
| Article | Year |
|---|---|
The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy.
Topics: Arginine; Biomarkers; Cardiomyopathies; Cardiomyopathy, Dilated; Chromatography, Liquid; Creatinine; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Peptide Fragments; Severity of Illness Index; Tandem Mass Spectrometry | 2012 |
Urotensin II and cardiomyopathy in end-stage renal disease.
Topics: Adult; Aged; Arginine; Cardiomyopathies; Cardiotonic Agents; Echocardiography; Female; Heart Atria; Humans; Kidney Failure, Chronic; Male; Medical Records; Middle Aged; Multivariate Analysis; Nitric Oxide; Sympathetic Nervous System; Urotensins; Ventricular Function, Left | 2008 |